Clinical Trial Update: A Phase IV Study to Collect Data on the Efficacy and Safety of RIBociclib in Older Women With Breastcancer

View source ↗

Summary

Phase IV trial update assessing the efficacy and safety of ribociclib in older women with breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• KISQALI (ribociclib)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Breast Cancer | Status: COMPLETED